Advances and Pitfalls of Specialized Pain Care through Public and Private Health Care Providers in Catalonia and the Balearic Islands: A Physician's Survey.

Authors:
Medel J; Serrano A; Batet C; Lorente L; Bella S and 7 more

Journal:
Pain Res Manag

Publication Year: 2022

DOI:
10.1155/2022/4077139

PMCID:
PMC9148249

PMID:
35637851

Journal Information

Full Title: Pain Res Manag

Abbreviation: Pain Res Manag

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest AS has received honoraria for the Advisory Board from Esteve and consultancy fees from Grünenthal Pharma, Kyowa Kirin, Esteve, and Neuraxpharm, and travel and congress fees have been financed by Grünenthal Pharma and Neuraxpharm. JV has received honoraria for drafting manuscripts for Grünenthal Pharma, Lilly, and Esteve and has received consultancy fees from Amadix, Grünenthal Pharma, Esteve, Novartis, and Vivia Biotech. The remaining authors declare that they have no conflicts of interest regarding the publication of this paper."

Evidence found in paper:

"The authors thank all respondents from Catalonia and the Balearic Islands, without whom this work would not have been possible. Also, thanks to Esther Garcia-Lerma MSc and Cristian Tebé MSc PhD from UBiDi (Unitat Bioestadística IDIBELL) for their support on REDCap electronic data capture tools and statistical analysis, Sarah Cousins for her proofreading and editing of the English language during manuscript preparation, and Mr. Jaume Solé (Acadèmia Ciències Mèdiques de Catalunya, the authors de Balears) for his support in sending the emails to potential participants. This research has received funds from the Catalan Pain Society."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025